Description
Developer of ovarian cancer drug. The company develops drugs which destroys the cancer stem cells.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Name | Title | Board Seat | Contact Info |
---|---|---|---|
David Brown Ph.D | Chief Scientific Officer | ||
Andrew Heaton Ph.D | Vice President, Drug Discovery | ||
Graham Kelly Ph.D | Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|